I have developed a 3 color phenotyping method that is similar to CD45 gating
using CD20 that is very good at "finding" very small populations of abnormal
B-cells in bone marrow and blood. What I'd like to know is if anybody is
using CD20 as a third color for gating on B-cells to diagnose B-cell
leukemias for clinical purposes. I would greatly appreciate anyone's
response to my inquiry. Thanks in advance.
Hector Pulido
Flowman@aol.com